Clinical Trials Directory

Trials / Completed

CompletedNCT01089400

Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage

Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage in Patients Requiring Mechanical Ventilation in Intensive Care Unit

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France · Other Government
Sex
All
Age
13 Years
Healthy volunteers
Not accepted

Summary

The influenza A/H1N1v pandemic virus causes severe pneumonia that can lead to acute respiratory distress syndrome and death even in healthy young individuals. The respective roles of viral replication, bacterial infection and immune alterations of the host during such severe influenza H1N1v infection need to be clarified in order to optimize patients care. In this context, we aim to study immune and virological parameters in bronchoalveolar lavage fluid during severe influenza A/H1N1v infection with pulmonary involvement in intensive care unit. Results will be correlated to bacterial or viral pulmonary co-infections and to peripheral blood immune and virological parameters.

Conditions

Timeline

Start date
2009-10-01
Primary completion
2011-04-01
Completion
2011-04-01
First posted
2010-03-18
Last updated
2025-12-04

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01089400. Inclusion in this directory is not an endorsement.

Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage (NCT01089400) · Clinical Trials Directory